Item 7.01 Regulation FD Disclosure
Beginning at 1:00 a.m. ET on September 13, 2021, in connection with its senior
management presenting at the H.C. Wainwright 23rd Annual Global Investment
Conference being held September 13-15, 2021, Cocrystal Pharma, Inc. (the
"Company") is making available a webcast of the presentation on its website. A
copy of the slide presentation is being furnished as Exhibit 99.1 hereto and is
incorporated herein by reference.
The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the
"Exchange Act") or otherwise subject to the liabilities under such section, and
shall not be deemed to be incorporated by reference into any filing of the
Company under the Securities Act of 1933, or the Exchange Act.
Item 9.01 Financial Statements and Exhibits
99.1 Cocrystal Pharma, Inc. Corporate Presentation, dated September 2021
104 Cover Page Interactive Data File (embedded within the Inline XBRL
© Edgar Online, source Glimpses